Augmedix Inc. (AUGX)
NASDAQ: AUGX
· Real-Time Price · USD
2.35
0.00 (0.00%)
At close: Oct 01, 2024, 9:57 PM
Augmedix Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 13.66M | 13.47M | 12.68M | 11.77M | 10.78M | 9.63M | 8.75M | 7.86M | 7.33M | 6.99M | 6.58M | 5.63M | 5.17M | 4.79M |
Cost of Revenue | 7.21M | 7.13M | 6.43M | 5.94M | 5.71M | 5.24M | 4.7M | 4.27M | 4.13M | 3.87M | 3.64M | 3.09M | 2.76M | 2.67M |
Gross Profit | 6.46M | 6.34M | 6.25M | 5.83M | 5.07M | 4.39M | 4.05M | 3.59M | 3.2M | 3.11M | 2.94M | 2.53M | 2.41M | 2.13M |
Operating Income | -8.72M | -6.4M | -4.35M | -4.4M | -4.93M | -5.65M | -5.44M | -5.46M | -6.05M | -5.45M | -4.83M | -4.67M | -4.04M | -4.4M |
Interest Income | 410K | 503K | 384K | 288K | 276K | 162K | 177K | 59K | 4K | 5K | 7K | 1K | 3K | 3.97K |
Pretax Income | -8.36M | -6.58M | -4.51M | -4.41M | -5.03M | -5.24M | -5.6M | -5.49M | -7.45M | -5.94M | -5.45M | -2.86M | -4.64M | -4.9M |
Net Income | -8.45M | -6.5M | -4.49M | -4.41M | -5.03M | -5.27M | -5.76M | -5.52M | -8.84M | -5.94M | -5.45M | -2.86M | -4.64M | -4.9M |
Selling & General & Admin | 10.76M | 8.91M | 7.65M | 7.3M | 7.41M | 6.77M | 6.88M | 6.44M | 6.6M | 6.28M | 5.82M | 5.39M | 4.95M | 5.1M |
Research & Development | 4.42M | 3.83M | 2.94M | 2.94M | 2.59M | 2.71M | 2.61M | 2.61M | 2.65M | 2.28M | 1.94M | 1.81M | 1.5M | 1.43M |
Other Expenses | n/a | -64K | 94K | -4K | -99K | n/a | n/a | -32K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 15.18M | 12.74M | 10.59M | 10.23M | 10M | 9.48M | 9.49M | 9.05M | 9.25M | 8.56M | 7.76M | 7.21M | 6.45M | 6.53M |
Interest Expense | 639K | 616K | 645K | 642K | 558K | 408K | 373K | 316K | 385K | 601K | 613K | 589K | 605K | 691.55K |
Selling & Marketing Expenses | 3.75M | 3.56M | 2.75M | 2.73M | 2.65M | 2.56M | 2.34M | 2.3M | 2.43M | 2.23M | 2.05M | 2.16M | 1.73M | 1.57M |
Cost & Expenses | 22.39M | 19.87M | 17.03M | 16.17M | 15.71M | 14.72M | 14.19M | 13.32M | 13.38M | 12.43M | 11.4M | 10.3M | 9.21M | 9.19M |
Income Tax Expense | 86K | -80K | -24K | 84K | 51K | 33K | 159K | 32K | 1.4M | -339K | n/a | 810K | 3K | n/a |
Shares Outstanding (Basic) | 53.39M | 53.06M | 49.02M | 45.52M | 43.61M | 37.49M | 37.44M | 37.43M | 37.42M | 37.4M | 34.42M | 27.12M | 27.02M | 26.86M |
Shares Outstanding (Diluted) | 53.39M | 53.06M | 49.02M | 45.52M | 43.61M | 37.49M | 37.44M | 37.43M | 37.42M | 37.4M | 34.65M | 27.12M | 27.02M | 26.86M |
EPS (Basic) | -0.16 | -0.12 | -0.09 | -0.1 | -0.12 | -0.14 | -0.15 | -0.15 | -0.24 | -0.16 | -0.16 | -0.11 | -0.17 | -0.18 |
EPS (Diluted) | -0.16 | -0.12 | -0.09 | -0.1 | -0.12 | -0.14 | -0.15 | -0.15 | -0.24 | -0.16 | -0.16 | -0.11 | -0.17 | -0.18 |
EBITDA | -7.31M | -5.96M | -4.04M | -3.43M | -4.16M | -4.71M | -5.09M | -5M | -6.05M | -5.23M | -4.66M | -1.99M | -3.87M | -4.2M |
EBIT | -7.72M | -5.96M | -3.87M | -3.68M | -4.42M | -4.8M | -5.12M | -5.16M | -6.95M | -5.41M | -4.84M | -2.15M | -4.03M | -4.21M |
Depreciation & Amortization | 416K | 439K | 306K | 463K | 407K | 389K | 349K | 458K | 382K | 339K | 168K | 156K | 200K | 201.59K |